Evidences of in vivo bioactivity of Fe-bioceramic composites for temporary bone implants

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 103, Issue 7, 2015, Pages 1354-1365

  Ulum, Mokhamad F ^a,b   Nasution, Ahmad K ^a,c   Yusop, Abdul H ^a   Arafat, Andril ^a   Kadir, Mohammed Rafiq A ^a   Juniantito, Vetnizah ^b   Noviana, Deni ^b   Hermawan, Hendra ^a,d  

^a UNIVERSITI TEKNOLOGI MALAYSIA   (Malaysia)

^b BOGOR AGRICULTURAL UNIVERSITY   (Indonesia)

^c UNIVERSITY OF RIAU   (Indonesia)

^d University Laval   (Canada)

Author keywords

bioactive; bioceramics; biodegradable metals; composites; in vivo

Indexed keywords

BIODEGRADATION; BLOOD; BONE; COMPOSITE MATERIALS; IRON; IRON COMPOUNDS; TISSUE REGENERATION;

BIOACTIVE; BIOCERAMIC COMPOSITES; BIODEGRADABLE IMPLANTS; BIODEGRADABLE METALS; HISTOLOGICAL ANALYSIS; IMPLANTATION PERIODS; IN-VIVO; WOUND HEALING PROCESS;

BIOCERAMICS;

BIOCERAMICS; CALCIUM PHOSPHATE; HYDROXYAPATITE; IRON BCP; IRON HYDROXYAPATITE; IRON TRICALCIUM PHOSPHATE; UNCLASSIFIED DRUG; BONE PROSTHESIS; IRON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; BLOOD SAMPLING; BONE IMPLANT; CELL COUNT; CONTROLLED STUDY; GIANT CELL; HISTOCOMPATIBILITY; IN VIVO STUDY; INFLAMMATORY CELL; MALE; NONHUMAN; RADIUS; REAL TIME ECHOGRAPHY; SHEEP; STRESS; TISSUE REACTION; WOUND HEALING; ANIMAL; BONE PROSTHESIS; CERAMICS; CHEMISTRY; MATERIALS TESTING; PHARMACOKINETICS; PHARMACOLOGY;

ANIMALS; BONE SUBSTITUTES; CERAMICS; IRON; MALE; MATERIALS TESTING; SHEEP;

EID: 84941641657     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.33315     Document Type: Article

References (62)

1. Kamitakahara M, Ohtsuki C, Miyazaki T,. Review paper: Behavior of ceramic biomaterials derived from tricalcium phosphate in physiological condition. J Biomater Appl 2008; 23: 197-212.
2. Surmenev RA, Surmeneva MA, Ivanova AA,. Significance of calcium phosphate coatings for the enhancement of new bone osteogenesis: A review. Acta Biomater 2014; 10: 557-579.
3. Shen JZ, Fäldt J,. Chapter 13: Requirements of bioactive ceramics for dental implants and scaffolds. In:, Shen JZ, Kosmač T, editors. Advanced Ceramics for Dentistry. Oxford: Butterworth-Heinemann; 2014. pp 279-300.
4. Samavedi S, Whittington AR, Goldstein AS,. Calcium phosphate ceramics in bone tissue engineering: A review of properties and their influence on cell behavior. Acta Biomater 2013; 9: 8037-8045.
5. Wang M,. Developing bioactive composite materials for tissue replacement. Biomaterials 2003; 24: 2133-2151.
6. Ohtsuki C, Kamitakahara M, Miyazaki T,. Bioactive ceramic-based materials with designed reactivity for bone tissue regeneration. J R Soc Interface 2009; 6 (Suppl 3): S349-360.
7. Tampieri A, D'Alessandro T, Sandri M, Sprio S, Landi E, Bertinetti L, Panseri S, Pepponi G, Goettlicher J, Banobre-Lopez M, Rivas J,. Intrinsic magnetism and hyperthermia in bioactive Fe-doped hydroxyapatite. Acta Biomater 2012; 8: 843-851.
8. Vlad MD, Şindilar EV, Mariñoso ML, Poeatə I, Torres R, Lõpez J, Baracoa M, Fernandez E,. Osteogenic biphasic calcium sulphate dihydrate/iron-modified α-tricalcium phosphate bone cement for spinal applications: In vivo study. Acta Biomater 2010; 6: 607-616.
9. Kokubo T, Kim HM, Kawashita M,. Novel bioactive materials with different mechanical properties. Biomaterials 2003; 24: 2161-2175.
10. Kokubo T, Kim HM, Kawashita M, Nakamura T,. Bioactive metals: Preparation and properties. J Mater Sci-Mater Med 2004; 15: 99-107.
11. Ignatius AA, Augat P, Hollstein E, Schorlemmer S, Peraus M, Pokinskyj P, Claes L,. Biocompatibility and functionality of the degradable polymer alkylene bis(dilactoyl)-methacrylate for screw augmentation in vivo. J Biomed Mater Res B 2005; 75: 128-136.
12. Sun L, Hu YY, Xiong Z, Wang WM, Pan Y,. Repair of the radial defect of rabbit with polyester/tricalcium phosphate scaffolds prepared by rapid prototyping technology. Chin J Traumatol 2006; 9: 298-302.
13. Yu D, Li Q, Mu X, Chang T, Xiong Z,. Bone regeneration of critical calvarial defect in goat model by PLGA/TCP/rhBMP-2 scaffolds prepared by low-temperature rapid-prototyping technology. Int J Oral Max Surg 2008; 37: 929-934.
14. Wen Z, Zhang L, Chen C, Liu Y, Wu C, Dai C,. A construction of novel iron-foam-based calcium phosphate/ chitosan coating biodegradable scaffold material. Mater Sci Eng C Mater Biol Appl 2013; 33: 1022-1031.
15. Chen H, Zhang E, Yang K,. Microstructure, corrosion properties and bio-compatibility of calcium zinc phosphate coating on pure iron for biomedical application. Mater Sci Eng C Mater Biol Appl 2014; 34: 201-206.
16. Witte F, Feyerabend F, Maier P, Fischer J, Störmer M, Blawert C, Dietzel W, Hort N,. Biodegradable magnesium-hydroxyapatite metal matrix composites. Biomaterials 2007; 28: 2163-2174.
17. Yu K, Chen L, Zhao J, Li S, Dai Y, Huang Q, Yu Z,. In vitro corrosion behavior and in vivo biodegradation of biomedical β-Ca3(PO4)2/Mg-Zn composites. Acta Biomater 2012; 8: 2845-2855.
18. Yu K, Chen L, Zhao J, Wang R, Dai Y, Huang Q,. In vivo biocompatibility and biodegradation of a Mg-15%Ca3(PO4)2 composite as an implant material. Mater Lett 2013; 98: 22-25.
19. Cheng J, Huang T, Zheng YF,. Microstructure, mechanical property, biodegradation behavior, and biocompatibility of biodegradable Fe-Fe2O3 composites. J Biomed Mater Res A 2013; 102: 2277-2287.
20. Ulum MF, Arafat A, Noviana D, Yusop AH, Nasution AK, Abdul Kadir MR, Hermawan H,. In vitro and in vivo degradation evaluation of novel iron-bioceramic composites for bone implant applications. Mater Sci Eng C Mater Biol Appl 2014; 36: 336-344.
21. De Aza PN, Luklinska ZB, Santos C, Guitian F, De Aza S,. Mechanism of bone-like formation on a bioactive implant in vivo. Biomaterials 2003; 24: 1437-1445.
22. Noviana D, Nasution AK, Ulum MF, Hermawan H,. Degradation of Fe-bioceramic composites at two different implantation sites in sheep animal model observed by X-ray radiography. Eur Cells Mater 2013; 26 (Suppl 5): S56.
23. Gerald M, Denise S,. A Practical Guide to Decontamination in Healthcare. New York: Wiley; 2012. pp 325.
24. Pearce AI, Richards RG, Milz S, Schneider E, Pearce SG,. Animal models for implant biomaterial research in bone: A review. Eur Cells Mater 2007; 13: 1-10.
25. Kuzyk PR, Schemitsch EH,. The basic science of peri-implant bone healing. Indian J Orthop 2011; 45: 108-115.
26. Ducheyne P, Qiu Q,. Bioactive ceramics: The effect of surface reactivity on bone formation and bone cell function. Biomaterials 1999; 20: 2287-2303.
27. Macfarlane PS, Reid R, Callander R,. Pathology Illustrated, 5th ed. Edinburgh: Churchill Livingstone; 2000.
28. Teefey SA, Middleton WD, Patel V, Hildebolt CF, Boyer MI,. The accuracy of high-resolution ultrasound for evaluating focal lesions of the hand and wrist. J Hand Surg-Am 2004; 29: 393-399.
29. Tchelepi H, Ralls PW,. Color comet-tail artifact: Clinical applications. Am J Roentgenol 2009; 192: 11-18.
30. Rojbani H, Nyan M, Ohya K, Kasugai S,. Evaluation of the osteoconductivity of alpha-tricalcium phosphate, beta-tricalcium phosphate, and hydroxyapatite combined with or without simvastatin in rat calvarial defect. J Biomed Mater Res A 2011; 98: 488-498.
31. Wood RC, LeCluyse EL, Fix JA,. Assessment of a model for measuring drug diffusion through implant-generated fibrous capsule membranes. Biomaterials 1995; 16: 957-959.
32. Erdmann N, Bondarenko A, Hewicker-Trautwein M, Angrisani N, Reifenrath J, Lucas A, Meyer-Lindenberg A,. Evaluation of the soft tissue biocompatibility of MgCa0.8 and surgical steel 316L in vivo: A comparative study in rabbits. Biomed Eng Online 2010; 9: 63.
33. Lange T, Schilling AF, Peters F, Haag F, Morlock MM, Rueger JM, Amling M,. Proinflammatory and osteoclastogenic effects of beta-tricalciumphosphate and hydroxyapatite particles on human mononuclear cells in vitro. Biomaterials 2009; 30: 5312-5318.
34. Puleo DA, Nanci A,. Understanding and controlling the bone-implant interface. Biomaterials 1999; 20: 2311-2321.
35. Ulum MF, Paramitha D, Estuningsih S, Noviana D, Hermawan H,. Metal ion level and polymorphonuclear leukocyte cells number as determination factors for early in vivo rejection of biodegradable metals. Eur Cells Mater 2013; 26 (Suppl 5): S59.
36. Al-Saffar N, Revell PA,. Pathology of the bone-implant interfaces. J Long-Term Eff Med Impl 1999; 9: 319-347.
37. Kubies D, Himmlova L, Riedel T, Chanova E, Balik K, Douderova M, Bartova J, Pesakova V,. The interaction of osteoblasts with bone-implant materials: 1. The effect of physicochemical surface properties of implant materials. Physiol Res 2011; 60: 95-111.
38. Ambore B, Ravikanth K, Maini S, Rekhe DS,. Haematological profile and growth performance of goats under transportation stress. Vet World 2009; 2: 195-198.
39. Kannan G, Terrill TH, Kouakou B, Gazal OS, Gelaye S, Amoah EA, Samake S,. Transportation of goats: Effects on physiological stress responses and live weight loss. J Anim Sci 2000; 78: 1450-1457.
40. Langton DJ, Sidaginamale RP, Joyce TJ, Natu S, Blain P, Jefferson RD, Rushton S, Nargol AV,. The clinical implications of elevated blood metal ion concentrations in asymptomatic patients with MoM hip resurfacings: A cohort study. BMJ Open 2013; 3: e001541.
41. Rambox drawings light down and leftrez-Pérez AH, Buntinx SE, Rosiles R,. Effect of breed and age on the voluntary intake and the micromineral status of non-pregnant sheep: II. Micromineral status. Small Ruminant Res 2000; 37: 231-242.
42. Walwadkar SD, Suryakar AN, Katkam RV, Kumbar KM, Ankush RD,. Oxidative stress and calcium-phosphorus levels in Rheumatoid arthritis. Indian J Clin Biochem 2006; 21: 134-137.
43. Conz MB, Granjeiro JM, Soares Gde A,. Hydroxyapatite crystallinity does not affect the repair of critical size bone defects. J Appl Oral Sci 2011; 19: 337-342.
44. Scholtysek C, Kronke G, Schett G,. Inflammation-associated changes in bone homeostasis. Inflamm Allergy Drug Targets 2012; 11: 188-195.
45. Schmutz P, Quach-Vu N-C, Gerber I,. Metallic medical implants: Electrochemical characterization of corrosion processes. Interface 2008; 17: 35-40.
46. Kannan MB, Raman RKS,. In vitro degradation and mechanical integrity of calcium-containing magnesium alloys in modified-simulated body fluid. Biomaterials 2008; 29: 2306-2314.
47. Bengtsson Å, Shchukarev A, Persson P, Sjöberg S,. A solubility and surface complexation study of a non-stoichiometric hydroxyapatite. Geochim Cosmochim Acta 2009; 73: 257-267.
48. Carrodeguas RG, De Aza S,. α-Tricalcium phosphate: Synthesis, properties and biomedical applications. Acta Biomater 2011; 7: 3536-3546.
49. Watanabe T,. Wettability of ceramic surfaces -A wide range control of surface wettability from super hydrophilicity to super hydrophobicity, from static wettability to dynamic wettability. J Ceram Soc Jpn 2009; 117: 1285-1292.
50. Pedersen A, Hermansson M,. Inhibition of metal corrosion by bacteria. Biofouling 1991; 3: 1-11.
51. Martínez IM, Meseguer-Olmo L, Bernabeu-Esclapez A, Velásquez PA, De Aza PN,. In vitro behavior of α-tricalcium phosphate doped with dicalcium silicate in the system Ca2SiO4-Ca3(PO4)2. Mater Charact 2012; 63: 47-55.
52. Shalabi MM, Wolke JG, Jansen JA,. The effects of implant surface roughness and surgical technique on implant fixation in an in vitro model. Clin Oral Implan Res 2006; 17: 172-178.
53. Suzuki K, Aoki K, Ohya K,. Effects of surface roughness of titanium implants on bone remodeling activity of femur in rabbits. Bone 1997; 21: 507-514.
54. Liu B, Lun DX,. Current application of beta-tricalcium phosphate composites in orthopaedics. Orthop Surg 2012; 4: 139-144.
55. Zhou AJ, Peel SA, Clokie CM,. An evaluation of hydroxyapatite and biphasic calcium phosphate in combination with pluronic F127 and BMP on bone repair. J Craniofac Surg 2007; 18: 1264-1275.
56. Hermawan H, Dubé D, Mantovani D,. Degradable metallic biomaterials: Design and development of Fe-Mn alloys for stents. J Biomed Mater Res A 2010; 93: 1-11.
57. Waksman R, Pakala R, Baffour R, Seabron R, Hellinga D, Tio FO,. Short-term effects of biocorrodible iron stents in porcine coronary arteries. J Interv Cardiol 2008; 21: 15-20.
58. Peuster M, Wohlsein P, Brugmann M, Ehlerding M, Seidler K, Fink C, Brauer H, Fischer A, Hausdorf G,. A novel approach to temporary stenting: Degradable cardiovascular stents produced from corrodible metal-results 6-18 months after implantation into New Zealand white rabbits. Heart 2001; 86: 563-569.
59. Peuster M, Hesse C, Schloo T, Fink C, Beerbaum P, von Schnakenburg C,. Long-term biocompatibility of a corrodible peripheral iron stent in the porcine descending aorta. Biomaterials 2006; 27: 4955-4962.
60. Ajeesh M, Francis BF, Annie J, Harikrishna Varma PR,. Nano iron oxide-hydroxyapatite composite ceramics with enhanced radiopacity. J Mater Sci-Mater Med 2010; 21: 1427-1434.
61. Gross KA, Jackson R, Cashion JD, Rodriguez-Lorenzo LM,. Iron substitute apatites: A resorbable biomaterial with potential magnetic properties. Eur Cells Mater 2002; 3 (Suppl 2): 114-117.
62. Hou CH, Hou SM, Hsueh YS, Lin J, Wu HC, Lin FH,. The in vivo performance of biomagnetic hydroxyapatite nanoparticles in cancer hyperthermia therapy. Biomaterials 2009; 30: 3956-3960.